DULANERMIN
UNII L65E7T81M5

Substance Identification & Data

This profile provides standardized clinical and technical data for Dulanermin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L65E7T81M5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 867153-61-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
L65E7T81M5
CAS Registry Number
867153-61-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DULANERMIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9020
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
SS-62
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dulanermin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DULANERMIN

Common Names & Synonyms

114-281-PROTEIN TRAIL (TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND) (SYNTHETIC HUMAN)
B LYMPHOCYTE STIMULATOR (HUMAN)
DULANERMIN [INN]
DULANERMIN [USAN]
DULANERMIN [WHO-DD]
HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 10 (TNF-RELATED APOPTOSIS-INDUCING LIGAND OR APO-2 LIGAND OR CD253 ANTIGEN)-(114-281)-PEPTIDE (C-TERMINAL PART OF THE EXTRACELLULAR DOMAIN), NONCOVALENT HOMOTRIMER

Technical Codes

AMG-951
APO2L/TRAIL